These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30859335)

  • 1. Surface Modification of Polymeric Nanoparticles with M2pep Peptide for Drug Delivery to Tumor-Associated Macrophages.
    Pang L; Pei Y; Uzunalli G; Hyun H; Lyle LT; Yeo Y
    Pharm Res; 2019 Mar; 36(4):65. PubMed ID: 30859335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages.
    Ngambenjawong C; Cieslewicz M; Schellinger JG; Pun SH
    J Control Release; 2016 Feb; 224():103-111. PubMed ID: 26772876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
    Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
    ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective targeting of tumor associated macrophages in different tumor models.
    Kakoschky B; Pleli T; Schmithals C; Zeuzem S; Brüne B; Vogl TJ; Korf HW; Weigert A; Piiper A
    PLoS One; 2018; 13(2):e0193015. PubMed ID: 29447241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colony-Stimulating Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the Polarization of Tumor-Associated Macrophages in Hepatocellular Carcinoma.
    Ao JY; Zhu XD; Chai ZT; Cai H; Zhang YY; Zhang KZ; Kong LQ; Zhang N; Ye BG; Ma DN; Sun HC
    Mol Cancer Ther; 2017 Aug; 16(8):1544-1554. PubMed ID: 28572167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Stability and Affinity Optimization of an M2 Macrophage-Targeting Peptide (M2pep).
    Ngambenjawong C; Gustafson HH; Pineda JM; Kacherovsky NA; Cieslewicz M; Pun SH
    Theranostics; 2016; 6(9):1403-14. PubMed ID: 27375788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted ferritin nanoparticle encapsulating CpG oligodeoxynucleotides induces tumor-associated macrophage M2 phenotype polarization into M1 phenotype and inhibits tumor growth.
    Shan H; Dou W; Zhang Y; Qi M
    Nanoscale; 2020 Nov; 12(43):22268-22280. PubMed ID: 33146206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 9. Target delivery selective CSF-1R inhibitor to tumor-associated macrophages via erythrocyte-cancer cell hybrid membrane camouflaged pH-responsive copolymer micelle for cancer immunotherapy.
    Wang Y; Luan Z; Zhao C; Bai C; Yang K
    Eur J Pharm Sci; 2020 Jan; 142():105136. PubMed ID: 31704343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival.
    Cieslewicz M; Tang J; Yu JL; Cao H; Zavaljevski M; Motoyama K; Lieber A; Raines EW; Pun SH
    Proc Natl Acad Sci U S A; 2013 Oct; 110(40):15919-24. PubMed ID: 24046373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M2pep-Modified Cyclodextrin-siRNA Nanoparticles Modulate the Immunosuppressive Tumor Microenvironment for Prostate Cancer Therapy.
    Sun Y; Cronin MF; Mendonça MCP; Guo J; O'Driscoll CM
    Mol Pharm; 2023 Nov; 20(11):5921-5936. PubMed ID: 37874541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Surface-Variable Polymeric Nanoparticles for Drug Delivery to Tumors.
    Han N; Pang L; Xu J; Hyun H; Park J; Yeo Y
    Mol Pharm; 2017 May; 14(5):1538-1547. PubMed ID: 28368124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage-Derived Nanosponges Adsorb Cytokines and Modulate Macrophage Polarization for Renal Cell Carcinoma Immunotherapy.
    Jiang Y; Nie D; Hu Z; Zhang C; Chang L; Li Y; Li Z; Hu W; Li H; Li S; Xu C; Liu S; Yang F; Wen W; Han D; Zhang K; Qin W
    Adv Healthc Mater; 2024 Aug; 13(20):e2400303. PubMed ID: 38647150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting tumor-associated macrophages with mannosylated nanotherapeutics delivering TLR7/8 agonist enhances cancer immunotherapy.
    Dang BN; Duwa R; Lee S; Kwon TK; Chang JH; Jeong JH; Yook S
    J Control Release; 2024 Aug; 372():587-608. PubMed ID: 38942083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted delivery of berberine using bionic nanomaterials for Atherosclerosis therapy.
    Wu H; Zhang L; Dong X; Yang J; Zheng L; Li L; Liu X; Jin M; Zhang P
    Biomed Pharmacother; 2024 Sep; 178():117135. PubMed ID: 39047421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFP-EGF1-conjugated poly (lactic-co-glycolic acid) nanoparticles as a carrier for the delivery of CCR2- shRNA to atherosclerotic macrophage in vitro.
    Wu Z; Chen C; Luo J; Davis JRJ; Zhang B; Tang L; Shi W; Liao D
    Sci Rep; 2020 Nov; 10(1):19636. PubMed ID: 33184330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-Based [
    Huang M; Wang R; Li M; Cai H; Tian R
    Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36432702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of Biodegradable PLGA-Nanoparticles Used for pH-Sensitive Intracellular Delivery of an Anti-inflammatory Bacterial Toxin to Macrophages.
    Harada A; Tsutsuki H; Zhang T; Lee R; Yahiro K; Sawa T; Niidome T
    Chem Pharm Bull (Tokyo); 2020; 68(4):363-368. PubMed ID: 32238653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy.
    Li M; Li M; Yang Y; Liu Y; Xie H; Yu Q; Tian L; Tang X; Ren K; Li J; Zhang Z; He Q
    J Control Release; 2020 May; 321():23-35. PubMed ID: 32035193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Pro-Tumoral Macrophages in Early Primary and Metastatic Breast Tumors with the CD206-Binding mUNO Peptide.
    Lepland A; Asciutto EK; Malfanti A; Simón-Gracia L; Sidorenko V; Vicent MJ; Teesalu T; Scodeller P
    Mol Pharm; 2020 Jul; 17(7):2518-2531. PubMed ID: 32421341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.